Align Technology (ALGN) Cash from Financing Activities (2009 - 2026)
Align Technology's (ALGN) quarterly Cash from Financing Activities came in at -$48.1 million in Q1 2026, up 76.72% year-on-year from -$27.2 million in Q1 2025, and up 50.59% on a QoQ basis from -$97.4 million in Q4 2025.
Align Technology (ALGN) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has 18 years of Cash from Financing Activities data on file, last reported at -$48.1 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 76.72% year-over-year to -$48.1 million in Q1 2026; TTM through Mar 2026 was -$306.0 million, a 44.45% increase from a year earlier, with the FY2025 full-year figure at -$464.6 million, down 30.6% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$48.1 million, up from -$97.4 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for ALGN reached as high as $11.8 million in Q3 2023 and fell as low as -$350.3 million in Q4 2023.
- Historically, Cash from Financing Activities has averaged -$115.8 million across 5 years, with a median of -$97.4 million in 2025.
- Across the five-year window, Cash from Financing Activities jumped 116.77% in 2022 and plunged 16179.16% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at -$200.2 million in 2022, then tumbled by 74.98% to -$350.3 million in 2023, then jumped by 42.04% to -$203.0 million in 2024, then surged by 52.02% to -$97.4 million in 2025, then jumped by 50.59% to -$48.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$48.1 million in Q1 2026, -$97.4 million in Q4 2025, and -$64.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.13 Mn |
| Mar 31, 2026 | -48.13 Mn |
| Dec 31, 2025 | -97.41 Mn |
| Dec 31, 2025 | -97.41 Mn |
| Sep 30, 2025 | -64.12 Mn |
| Sep 30, 2025 | -64.12 Mn |
| Jun 30, 2025 | -96.30 Mn |
| Jun 30, 2025 | -96.30 Mn |
| Mar 31, 2025 | -206.76 Mn |
| Mar 31, 2025 | -206.76 Mn |
| Dec 31, 2024 | -203.02 Mn |
| Dec 31, 2024 | -203.02 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | -151.56 Mn |
| Jun 30, 2024 | -151.56 Mn |
| Mar 31, 2024 | -11.72 Mn |
| Mar 31, 2024 | -11.72 Mn |
| Dec 31, 2023 | -350.28 Mn |
| Dec 31, 2023 | -350.28 Mn |